Cristy is a Managing Director in the Menlo Park, California office. She has been a senior member of the investment team since 2002 when she joined Lighthouse as a Principal. Cristy leads the LCP VI west coast healthcare practice, where her primary focus has been life sciences, medical devices and healthcare information technology. While at Lighthouse, Cristy's investments have included Anacor Pharmaceuticals (NASDAQ: ANAC), Avid Radiopharmaceuticals (acquired by Eli Lilly & Company), BiPar Sciences (acquired by Sanofi-aventis), Fluidigm (NASDAQ: FLDM) and Novacardia (acquired by Merck & Co., Inc.).
Before joining Lighthouse, Cristy had seven years of experience in public and private equity investing, most recently as a Senior Associate at Highland Capital Partners. Prior to Highland, Cristy spent five years at Robertson Stephens and Company in the Technology Research Group.
Cristy holds a BA in Psychology with a minor in Business from the University of California, Los Angeles.
cristy [at] lcpartners [dot] com